Target intelligence / Profile preview

Disulfide bridges in gel-forming mucin polymers

Molecular classification
Structural protein component, Post-translational modification
01

Overview

Gel-forming mucins, such as MUC5AC and MUC5B, are large glycoproteins that polymerize to form the structural framework of the mucus gel [1]. This polymerization occurs through the formation of intermolecular disulfide bridges between cysteine-rich domains located at the N- and C-termini of the mucin monomers [2]. These disulfide bonds are essential for the viscoelastic properties of mucus, which are necessary for effective mucociliary clearance and protection of the underlying epithelium [3]. In diseases like cystic fibrosis, COPD, and asthma, the mucus becomes excessively thick and difficult to clear due to increased mucin density and oxidative stress-induced cross-linking [4]. Mucolytic drugs, such as N-acetylcysteine (NAC), target these disulfide bridges by providing free thiol groups that reduce the covalent bonds, thereby breaking the large polymers into smaller, less viscous fragments [5]. This reduction in viscosity facilitates the clearance of mucus from the airways, though it must be balanced against the potential for airway irritation or disruption of the protective barrier [5]. Sources: [1] Thornton DJ, et al. Annu Rev Physiol. 2008;70:459-86. [2] Ridley C, et al. Biochem J. 2003;373(Pt 2):389-97. [3] Fahy JV, Dickey BF. N Engl J Med. 2010;363(23):2233-47. [4] Hansson GC. Nat Rev Gastroenterol Hepatol. 2020;17(9):539-54. [5] Sadowska AM. Paediatr Respir Rev. 2012;13(1):59-64.

Other names
Mucin disulfide bondsInter-mucin disulfide linkagesCysteine-mediated mucin cross-linksMucin polymers
02

Mechanism of action

Reduction of intermolecular disulfide bonds via thiol-disulfide exchange, leading to the fragmentation of high-molecular-weight mucin polymers and a subsequent decrease in mucus viscosity.

03

Biological functions

Mucus gel formationViscoelasticityAirway clearanceBarrier functionEpithelial protection
04

Disease associations

Cystic fibrosisChronic obstructive pulmonary disease (COPD)AsthmaBronchitisSinusitis
05

Safety considerations

BronchospasmAirway irritationDisruption of protective mucosal barrier
06

Interacting drugs

N-acetylcysteine

3 more in the full profile.

07

Biomarkers

Sputum viscosityMucin concentrationForced expiratory volume in 1 second (FEV1)

Beyond the preview

Go deeper on Disulfide bridges in gel-forming mucin polymers.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Disulfide bridges in gel-forming mucin polymers.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call